Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'

Evangelos Terpos, speaking at the European Hematology Association 2010 Congress in Barcelona, discusses his group's encouraging findings based on 10 years of experience with thalidomide, lenalidomide, and bortezomib.